Literature DB >> 25805619

Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography.

Sudhakar K Venkatesh1, Meng Yin, Naoki Takahashi, James F Glockner, Jayant A Talwalkar, Richard L Ehman.   

Abstract

PURPOSE: To compare accuracy of morphological features of liver on MRI and liver stiffness with MR elastography (MRE) for detection of significant liver fibrosis and cirrhosis.
MATERIALS AND METHODS: In this retrospective study, we evaluated 62 patients who underwent liver MRI with MRE and histological confirmation of liver fibrosis within 6 months. Two radiologists, blinded to histology results, independently evaluated liver parenchyma texture, surface nodularity, signs of volumetric changes, and portal hypertension for presence of significant fibrosis and cirrhosis. Two more readers independently calculated mean liver stiffness values with MRE. Interobserver agreement was evaluated with kappa and intra-class correlation coefficient (ICC) analysis. Diagnostic accuracy was assessed with area under receiver operating characteristic (AUROC) analysis. Comparison of AUROCs of MRI and MRE was performed.
RESULTS: Liver fibrosis was present in 37 patients. The interobserver agreement was poor to good (κ = 0.12-0.74) for MRI features and excellent for MRE (ICC 0.97, 95% CI 0.95-0.98). MRI features had 48.5%-87.9% sensitivity, 55.2%-100% specificity, and 71.5%-81.6% accuracy/for detection of significant fibrosis. MRE performed better with 100% sensitivity, 96.5% specificity, and 98.9% accuracy. For the detection of cirrhosis, MRE performed better than MRI features with 88.2% sensitivity (vs. 41.2%-82.3%), 91.1% specificity (vs. 64.4%-95.6%), and 93.5% accuracy (vs. 60.6%-80.5%). Among the MRI features, surface nodularity and overall impression had the best accuracies of 80.3% and 81.6% for detection of significant fibrosis, respectively. For cirrhosis, parenchyma texture and overall impression had the best accuracies of 80.5% and 79.7%, respectively. Overall, MRE had significantly greater AUROC than MRI features for detection of both significant fibrosis (0.98.9 vs 0.71-0.82, P < 0.001) and cirrhosis (0.93.5 vs. 0.61-0.80.5, P < 0.01).
CONCLUSION: MRE is superior to MRI for the non-invasive diagnosis of significant liver fibrosis and cirrhosis.

Entities:  

Mesh:

Year:  2015        PMID: 25805619      PMCID: PMC4739358          DOI: 10.1007/s00261-015-0347-6

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  61 in total

1.  Enlargement of hilar periportal space: a sign of early cirrhosis at MR imaging.

Authors:  K Ito; D G Mitchell; T Gabata
Journal:  J Magn Reson Imaging       Date:  2000-02       Impact factor: 4.813

2.  Evaluation of esophageal varices on liver computed tomography: receiver operating characteristic analyses of the performance of radiologists and endoscopists.

Authors:  Hyojin Kim; Dongil Choi; Geum-Youn Gwak; Joon Hyoek Lee; Moon Kyung Park; Hyang Ie Lee; Seong Hyun Kim; Sangyu Nam; Eun Young Yoo; Young Soo Do
Journal:  J Gastroenterol Hepatol       Date:  2009-04-13       Impact factor: 4.029

3.  Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

Authors:  Laurent Huwart; Christine Sempoux; Eric Vicaut; Najat Salameh; Laurence Annet; Etienne Danse; Frank Peeters; Leon C ter Beek; Jacques Rahier; Ralph Sinkus; Yves Horsmans; Bernard E Van Beers
Journal:  Gastroenterology       Date:  2008-04-04       Impact factor: 22.682

4.  Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.

Authors:  S G Cho; M Y Kim; H J Kim; Y S Kim; W Choi; S H Shin; K C Hong; Y B Kim; J H Lee; C H Suh
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

5.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

Authors:  Diego A Aguirre; Cynthia A Behling; Elliot Alpert; Tarek I Hassanein; Claude B Sirlin
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

6.  Magnetization transfer contrast imaging of liver cirrhosis.

Authors:  J H Chen; J W Chai; W C Shen
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct

7.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

8.  MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging.

Authors:  Laurent Huwart; Najat Salameh; Leon ter Beek; Eric Vicaut; Frank Peeters; Ralph Sinkus; Bernard E Van Beers
Journal:  Eur Radiol       Date:  2008-05-27       Impact factor: 5.315

9.  MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness?

Authors:  Yu Shi; Qiyong Guo; Fei Xia; Bogdan Dzyubak; Kevin J Glaser; Qiuju Li; Jiahui Li; Richard L Ehman
Journal:  Radiology       Date:  2014-06-02       Impact factor: 11.105

Review 10.  Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

Authors:  Julie Parkes; Indra Neil Guha; Paul Roderick; William Rosenberg
Journal:  J Hepatol       Date:  2005-11-21       Impact factor: 25.083

View more
  34 in total

Review 1.  Prediction of liver cirrhosis, using diagnostic imaging tools.

Authors:  Suk Keu Yeom; Chang Hee Lee; Sang Hoon Cha; Cheol Min Park
Journal:  World J Hepatol       Date:  2015-08-18

Review 2.  Non-invasive diagnosis of liver fibrosis and cirrhosis.

Authors:  Yoav Lurie; Muriel Webb; Ruth Cytter-Kuint; Shimon Shteingart; Gerardo Z Lederkremer
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

3.  MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes.

Authors:  Candice A Bookwalter; Sudhakar K Venkatesh; John E Eaton; Thomas D Smyrk; Richard L Ehman
Journal:  Abdom Radiol (NY)       Date:  2018-12

4.  Task-based optimization of flip angle for fibrosis detection in T1-weighted MRI of liver.

Authors:  Jonathan F Brand; Lars R Furenlid; Maria I Altbach; Jean-Philippe Galons; Achyut Bhattacharyya; Puneet Sharma; Tulshi Bhattacharyya; Ali Bilgin; Diego R Martin
Journal:  J Med Imaging (Bellingham)       Date:  2016-07-21

Review 5.  Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors:  Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2017-08

Review 6.  MR elastography of liver: current status and future perspectives.

Authors:  Ilkay S Idilman; Jiahui Li; Meng Yin; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2020-07-23

Review 7.  Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis.

Authors:  Suraj D Serai; Andrew T Trout; Alexander Miethke; Eric Diaz; Stavra A Xanthakos; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

8.  Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs.

Authors:  Christopher G Roth; Dina Halegoua-De Marzio; Flavius F Guglielmo
Journal:  Dig Dis Sci       Date:  2018-05       Impact factor: 3.199

Review 9.  Magnetic Resonance Elastography of Liver: Current Update.

Authors:  Safa Hoodeshenas; Meng Yin; Sudhakar Kundapur Venkatesh
Journal:  Top Magn Reson Imaging       Date:  2018-10

10.  Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease.

Authors:  Roberta Catania; Alessandro Furlan; Andrew D Smith; Jaideep Behari; Mitchell E Tublin; Amir A Borhani
Journal:  Eur Radiol       Date:  2020-08-05       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.